Results 61 to 70 of about 1,471,694 (149)
..................................... Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies.
Tomasz Olesiński
core +1 more source
For long years, patients and clinicians in Eastern China used Western data as information foundation for management and treatment of malignant mesothelioma, due to its rarity and lack of deep investigation. This study updated the epidemiological data of malignant mesothelioma in Eastern China, and revealed better survival outcomes compared to Western ...
Ningning Li +7 more
wiley +1 more source
Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. [PDF]
OBJECTIVE: This study aims to identify favorable preoperative characteristics and examine the impact of secondary cytoreductive surgery on survival for patients with recurrent epithelial ovarian carcinoma.
Palmer, James M +5 more
core +1 more source
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto +12 more
wiley +1 more source
Inhibition of P‐glycoprotein using photoimmunotherapy in peritoneal metastasis mouse model
Photoimmunotherapy (PIT) using photoimmunoconjugates (PICs) can inhibit the function of the ATP‐binding cassette (ABC) transporter P‐glycoprotein (P‐gp) in a mouse model of peritoneal carcinomatosis. Sterile‐filtered PIC was administered in vivo via intraperitoneal (IP) injection 20 days after IP tumor cell implantation of P‐gp‐overexpressing NCI/ADR ...
Kaitlyn A. Moore +6 more
wiley +1 more source
Laura M Enomoto, Perry Shen, Edward A Levine, Konstantinos I VotanopoulosWake Forest Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USAAbstract: Malignant peritoneal mesothelioma (MPM) is a rare, aggressive malignancy that ...
Enomoto LM +3 more
core
Cytoreductive Surgery for recurrent epithelial ovarian cancer
We aim to evaluate the benefits and hamrs of secondary cytoreductive surgery plus chemotherapy versus chemotherapy alone for women with recurrent epithelial ovarian ...
Ashraf Nabhan
core +1 more source
Cytoreductive surgery for advanced-stage ovarian cancer
Usually, ovarian cancer develops asymptomatically. Nearly 30%-40% of the newly-diagnosed cases are already at III-IV stage of FIGO. In such patients, there are metastases on the peritoneum of the whole abdominal cavity.
Slavchev, Stanislav; Medical University of Varna +1 more
core +1 more source
The impact of extensive cytoreductive surgery for ovarian cancer on the histopathology laboratory workload [PDF]
Objectives: Cytoreductive surgery is the principal management for ovarian cancer. Recently there has been progressive change to more extensive cytoreductive surgery (ECS) as evidence shows this improves patient prognosis. The aim of this
Mona El Bahrawy +3 more
core +1 more source
ABSTRACT Although osteosarcoma is the most common primary bone tumour in dogs, involvement of the pelvic bones is rare. The aim of the present study was to describe clinical presentation, identify possible prognostic factors, and evaluate outcomes in dogs diagnosed with pelvic osteosarcoma.
Csilla Fejös +15 more
wiley +1 more source

